These effects, together with a earlier report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 help the thought of focusing on ACKR3 as a novel method to modulate the opioid program, which could open new therapeutic avenues for opioid-connected Diseases. Importantly, these receptors have been https://thomass268nlw1.blogpixi.com/profile